期刊文献+

血浆一氧化氮水平与肝功能在梗阻性黄疸患者中的相关分析

Multiple Correlation Analysis between Level of Plasma Nitric Oxide and Liver Fun ction in Patients with Obstructive Jaundice
下载PDF
导出
摘要 目的 :初步探讨梗阻性黄疸患者血浆一氧化氮 (NO)变化规律及可能的机制。方法 :19例梗阻性黄疸 (梗黄组 )患者不伴感染及其它严重合并症 ,其中良性梗阻6例 ,恶性梗阻13例。同期非梗阻性无感染胆囊疾病患者9例为对照 ,检测血浆NO及肝功能 ,并将NO与肝功能行相关分析。结果 :梗黄组与对照组相比 ,NO水平显著性降低 ,其中恶性梗阻组与良性胆道梗阻组相比 ,血NO有显著性差异(P<0.01) ,恶性梗阻组血浆NO进一步降低。NO与肝功能相关分析结果提示NO与总胆红素 (TB)及碱性磷酸酶 (ALP)呈负相关 ,经检验有显著性意义。结论 :(1)梗阻性黄疸时NO水平降低。 (2)梗阻性黄疸时血浆NO水平与TB。 Objective:To investigate the rule of plasma nitric oxide(NO)change in patie nts with obstructive jaundice and its possible mechanism.Methods:The level of pl asma NO and liver function were measured in 19 patients with obstructive jaundic e(benign:6,malignant:13)and 9 normal controls.The multiple correlation analysis between the level of plasma NO and liver function was made.Results:The level of plasma NO in patients with obstructive jaundice was significantly lower than tha t in controls.The level of plasma NO in patients with malignant obstructive jaun dice was significantly lower than that in patients with benign obstructive jaund ice(P<0.01).There was a remarkably negative correlation between the level of pla sma NO and TB/ALP( NO/TB=-0.663 0,P=0.013 5; NO/ALP=-0.740 0,P=0.003 8).Conc lusion:(1)The level of plasma NO decreases in patients with obstructive jaundice .(2)There is a negative correlation between the level of plasma NO and the obstr uctive degree.
出处 《天津医药》 CAS 北大核心 2002年第11期653-655,共3页 Tianjin Medical Journal
关键词 肝功能 血浆 一氧化氮 胆汁郁积 梗阻性黄疸 plasma nitric oxide cholestasis
  • 相关文献

参考文献3

二级参考文献26

  • 1梅小君,顾正中.一氧化氮对脑血流的调节[J].生理科学进展,1995,26(1):35-39. 被引量:13
  • 2Wu Y,Burns RC.Sitzmann JV.Effects of nitric oxide and cyclooxygenase inhibition on splanchnic hemodynamics in portal hypertension.Hepatology,.1993;18(6):1416.
  • 3Sogni P.Morseu R.Ohsugn M.et al.Evidence for normal nitric oxide madlated vaso-dilator tone in conscicue rats with cirrhosis.Hepatology,1992;16(4):980.
  • 4Iwata F,Joh T,Kawai T,et al.Role of EDRF in splanchnic blood flow of normal and chronic portal hypertensive rats.Am J Physiol.1992;263(4):G149.
  • 5Mosca P,Lee FY,Kaumann AJ,et al.Pharmacology of portal-systemic collaterals in portal hypertensive rats:role of endothelium.Am J Physiol.1992;263(4 pt 1):G544.
  • 6Lee FY,Wang SS.Tsai YT,et al.Aminoguanidine corrects hyperdynamic circulation without ameliorating portal hypertension and portal hypertensive gastropathy in anesthetized portal hypertensive rats.J Hepatol.1997;26(3):687.
  • 7Michielsen PP.Pelckmans A.Haemodynamic changes in portal hypertension:new insights in the pathogenesis and clinical implications.Acta Gastroenterol Belg.1994;57(2):194.
  • 8Lee FY.Colombato LA.Albillos A.et al.Administration of N omega-nitro-L-arginine ameliorates portal-systemic shunting in portal-hypertensive rats.Gastroenterology.1993;105(5):1464.
  • 9Martin PY.Schrier RW.Pathogensais of water and sodium retention in cirrhosis.Kidney Int Suppl.1997;59(3):S43.
  • 10Roberts LR.Kamath PS.Ascites and hepatorenal syndrome:pathophysiology and management.Mayo Clin Proc.1996;71(4):9.

共引文献80

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部